Written by We are thrilled to be part of the VUMC team awarded funding from the Augmented Intelligence in Medicine and Healthcare Initiative (AIM-HI) Coordinating Center at Kaiser Permanente for the project “Advancing Novel Approaches and Best Practices for Effective AI-Enabled Diagnosis using Randomized Trials, Algorithmovigilance, and Proactive Risk Assessment.” Project funding is supported by the Gordon and Betty Moore Foundation with the goal to pursue research projects deploying artificial intelligence (AI) and machine learning (ML) algorithms to enhance diagnostic decision-making in health care.
Our team is led by Peter Embí, MD, MS, primary principal investigator and professor and chair of the Department of Biomedical Informatics (DBMI) and Senior Vice President for Research and Innovation at VUMC. Co-PIs include DBMI’s Laurie Novak, PhD, MHSA, Megan Salwei PhD, MS, and Colin Walsh, MD, MA.Co-Investigators include Adam Wright, PHD, Bradley Malin, PhD, Sharon Davis, PhD, MS, Michael Matheny, MD, MS, MPH, Shannon Walker, MD, Allison Wheeler, MD, MSCI, Amanda Mixon, MD, MS, MSPH, and Benjamin French, PhD, MS.
This project will evaluate hospital-acquired venous thromboembolism (HA-VTE)-specific AI-driven clinical decision support (AI-CDS) systems across rural and urban sites, and adult and pediatric patients. Additionally, we will study and refine novel approaches for real-world algorithmovigilance, focusing on real-time and sustained monitoring of AI tools that are deployed and actively used in the health care system. Read more at VUMC News here.
Walsh Science 